Opinion Editorial the National Institute of Neurological Disorders and Stroke– If the Atrial Cardiopathy and Antithrombotic Drugs in Pre- funded Atrial Cardiopathy and Antithrombotic Drugs in Pre- vention After Cryptogenic Stroke Trial and other similar vention After Cryptogenic Stroke Trial will test the hypoth- trials turn out positive, then this would suggest that preci- esis that the anticoagulant apixaban is superior to aspirin sion medicine markers may be more useful for making for patients with unexplained stroke who also have one treatment decisions than current etiologic classification of several biomarkers indicative of left atrial cardiopathy. systems. ARTICLE INFORMATION Definitions for use in a multicenter clinical trial: Trial Investigators. Comparison of warfarin and TOAST: Trial of Org 10172 in Acute Stroke aspirin for symptomatic intracranial arterial Author Affiliation: Departments of Neurology and Treatment. Stroke. 1993;24(1):35-41. stenosis. N Engl J Med. 2005;352(13):1305-1316. Epidemiology, College of Physicians and Surgeons and Mailman School of Public Health, Columbia 2. Hart RG, Diener HC, Coutts SB, et al; Cryptogenic 9. Jickling GC, Xu H, Stamova B, et al. Signatures of University, New York, New York. Stroke/ESUS International Working Group. Embolic cardioembolic and large-vessel ischemic stroke. strokes of undetermined source: the case for a new Ann
JAMA Neurology – American Medical Association
Published: Apr 20, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera